Adding Afinitor to Herceptin, the main treatment for HER2-positive metastatic breast cancer, helps some women with disease that has been resistant to previous Herceptin-based therapies, according to a new study.

Source: Targeted agent addition to hercepti...astatic HER-2 breast cancer, study finds